Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders

Use of metformin and analogs thereof to reduce RAN protein levels in the treatment of neurological disorders

US Patent 11903910 · Granted Feb 20, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunoassays for detection of ran proteins2025
Regulation of RAN translation by PKR and eIF2α-P pathways2025
Regulation of RAN translation by PKR and eIF2α-P pathways2025
Detection of antibodies against RAN proteins from serum and tissue lysates2025
Methods for diagnosing Huntington's Disease2025
Manipulation of eIF3 to modulate repeat associated non-ATG (RAN) translation2025
Manipulation of eIF3 to modulate repeat associated non-ATG (RAN) translation2025
Use and treatment of di-amino acid repeat-containing proteins associated with AL2025
Use and treatment of di-amino acid repeat-containing proteins associated with AL2025
Use and treatment of di-amino acid repeat-containing proteins associated with AL2024
Use and treatment of di-amino acid repeat-containing proteins associated with AL2024
Regulation of RAN translation by PKR and eIF2A-P pathways2022